rxmd: the income statement

MyFinsight

For the quarter ending 2024-06-30, RXMD made $13,477K in revenue. -$9,276K in net income. Net profit margin of -68.83%.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Income Statement	2024-06-30
Revenues, net	13,477
Costs of revenue	8,782
Gross profit	4,695
Selling, general, and administrative	895
Impairment loss	9,792
Salaries and wages	2,166
Professional fees	384
Depreciation and amortization	757
Total operating expenses	13,994
Loss from operations	-9,299
Interest income	40
Us-gaap_interestexpensenonoperating	17
Us-gaap_nonoperatingincomeexpense	23
Us-gaap_incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest	-9,276
Net income (loss)	-9,276

Basic eps	-1.49
Diluted eps	-1.49
Basic average shares	6,241,000
Diluted average shares	6,241,000

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Income Statement	2024-06-30
Revenues, net	13,477
Costs of revenue	8,782
Gross profit	4,695
Selling, general, and administrative	895
Impairment loss	9,792
Salaries and wages	2,166
Professional fees	384
Depreciation and amortization	757
Total operating expenses	13,994
Loss from operations	-9,299
Interest income	40
Us-gaap_interestexpensenonoperating	17
Us-gaap_nonoperatingincomeexpense	23
Us-gaap_incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest	-9,276
Net income (loss)	-9,276

Basic eps	-1.49
Diluted eps	-1.49
Basic average shares	6,241,000
Diluted average shares	6,241,000

rxmd: the income statement